The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Adhesion events in angiogenesis
Abstract
Recent work from several laboratories indicates that the coordination of endothelial cell adhesion events with growth factor receptor inputs regulates endothelial cell responses during angiogenesis. Analyses of the signaling pathways downstream of integrins, cadherins and growth-factor receptors are providing an insight into the molecular basis of known anti-angiogenic strategies, as well as into the design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lack of angiogenesis could also be due to the inability of the endothelial cells to adhere to each other and form tubes [66].”
From Tobacco toxins deposited on surfaces (third hand smoke) impair wound healing (2016) · cites this paper as [66]
Citations
Cites
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Self-citationIntegrins: Emerging Paradigms of Signal Transduction
Schwartz, M. A., Schaller, M. D., & Ginsberg, M. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003001 · Cited by 1,603
Brooks, P. C., Strömblad, S., Sanders, L. C., Schalscha, T. V., Aimes, R. T., Stetler‐Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,566
Self-citationThe extracellular matrix as a cell survival factor.
Meredith, J. E., Fazeli, B., & Schwartz, M. A. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.953 · Cited by 1,527
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,310
Self-citationHiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,086
Good, D. J., Polverini, P. J., Rastinejad, F., Beau, M. M. L., Lemons, R. S., Frazier, W. A., & Bouck, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,051
Research works printed but not linked: 1
- Kumar, 2001, Inhibition of angiogenesis and tumor growth by SCH221153, a dual αvβ3 and αvβ5 integrin receptor antagonist, Cancer Res, 61, 2232
Cited by
Sorted by citations
Items 201–288 of 288
Increased antitumor activity of tumor-specific peptide modified thymopentin
Lao, X., Li, B., Liu, M., Chen, J., Gao, X., & Zheng, H. (2014) · Biochimie · doi:10.1016/j.biochi.2014.09.013 · Cited by 15
Ye, H., Zhang, W., Xie, Z., Xu, N., & Lu, Y. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0687-2 · Cited by 16
Goonoo, N. (2018) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/aaab03 · Cited by 14
Kim, T. Y., Kim, J., Choo, H. P., & Kwon, H. J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.078 · Cited by 12
Use of RNA interference to inhibit integrin subunit αV-mediated angiogenesis
Graef, T. T., Steidl, U. G., Nedbal, W., Rohr, U. P., Fenk, R. R., Haas, R. R., & Kronenwett, R. (2006) · Angiogenesis · doi:10.1007/s10456-005-9026-5 · Cited by 12
Characterization of the Integrin αvβ3 in Arteriovenous Malformations and Cavernous Malformations
Lim, M. K., Haddix, T. L., Harsh, G. R., Vogel, H. S., Steinberg, G. K., & Guccione, S. (2005) · Cerebrovascular Diseases · doi:10.1159/000086123 · Cited by 12
Alpha V Integrin Prolongs Collagenase Production Through Jun Activation Binding Protein 1
Levinson, H., Sil, A. K., Conwell, J. E., Hopper, J. E., & Ehrlich, H. P. (2004) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000112281.97409.a6 · Cited by 11
Duan, J., Qian, G., Zhang, H., Wang, F., Tian, Q., Lei, D., & Zhao, J. (2025) · Advanced Science · doi:10.1002/advs.202414362 · Cited by 10
Haskali, M. B., Denoyer, D., Noonan, W., Cullinane, C. M., Rangger, C. A., Pouliot, N., Haubner, R., Roselt, P. D., Hicks, R. J., & Hutton, C. A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01062 · Cited by 10
SCUBE3 serves as an independent poor prognostic factor in breast cancer
Huo, Q., He, X., Li, Z., Yang, F., He, S., Shao, L., Hu, Y., Chen, S., & Xie, N. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01947-3 · Cited by 10
Angiogenic Response of Endothelial Cells to Fibronectin
Kumar, V. B. S., Viji, R. I., Kiran, M. S., & Sudhakaran, P. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3381-1_10 · Cited by 10
Kanda, S., Miyata, Y., & Kanetake, H. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20354 · Cited by 10
Vizza, E., CORRER, S., Barberini, F., Heyn, R., Bianchi, S., & Macchiarelli, G. (2005) · Journal of Reproduction and Development · doi:10.1262/jrd.17022 · Cited by 9
Melanoma: targeting signaling pathways and RaLP
Pasini, L., Turco, M. Y., Luzi, L., Aładowicz, E., Fagiani, E., & Lanfrancone, L. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802607363 · Cited by 10
Suda, H., Asami, Y., Murata, E., Fujita, K., & Akita, M. (2004) · PubMed · doi:10.14670/hh-19.735 · Cited by 9
Yang, Z., Yu, X., Chen, J., Ma, W., Hao, J., & Wu, C. (2025) · Small · doi:10.1002/smll.202500975 · Cited by 8
Chapter 11 Vascular Integrin Signaling
Mahabeleshwar, G. H., & Byzova, T. V. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)02011-9 · Cited by 8
Halder, S. K., Sapkota, A., & Milner, R. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01749-4 · Cited by 7
Yan, Y., Jiang, F., Lai, Y., Wang, H., Liu, A., Wang, C., Zhang, Y., Teng, W., & Shan, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091484 · Cited by 7
Cherukula, K., Uthaman, S., & Park, I. (2019) · Molecules · doi:10.3390/molecules24050885 · Cited by 7
Expression of integrins on human choroidal neovascular membranes
Cui, J. Z., Maberley, D., Samad, A., Ma, P., Ning, A., Matsubara, J. A., & Baciu, P. (2009) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-009-9015-9 · Cited by 7
Wang, X., Hao, Q., Zhao, Y., Guo, Y., & Ge, W. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600093 · Cited by 6
da Silva, T. H. Á., Butera, A. P., Leal, D. H. S., & Alves, R. J. (2007) · Revista Brasileira De Ciencias Farmaceuticas · doi:10.1590/s1516-93322007000100002 · Cited by 6
Niche-Mediated Integrin Signaling Supports Steady-State Hematopoiesis in the Spleen
Mehatre, S. H., Roy, I. M., Biswas, A., Prit, D., Schouteden, S., Huelsken, J., Verfaillie, C. M., & Khurana, S. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001066 · Cited by 6
Focal adhesion kinase and angiogenesis. Where do we go from here?
RIZZO, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.011 · Cited by 6
Angiogenesis Signaling Pathways as Targets in Cancer Therapy
Whipple, C. A., & Korc, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00333-8 · Cited by 5
Maira, S.-M., Pearson, M. A., Fabbro, D., & Garcı́a-Echeverrı́a, C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00202-9 · Cited by 6
Noninvasive Imaging in Drug Discovery and Development
Rudin, M., ALLEGRINI, P. R., Beckmann, N., Gremlich, H. U., Kneuer, R., Laurent, D., Rausch, M., & Stoeckli, M. (2004) · Springer eBooks · doi:10.1007/978-3-662-07310-0_3 · Cited by 5
Shen, L., Zhu, X., Wang, Y., Zeng, W., Wu, G., Xue, H., & Chen, B. (2007) · Biological Chemistry · doi:10.1515/bc.2008.016 · Cited by 5
Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor
Islam, A. (2006) · Frontiers in bioscience · doi:10.2741/1973 · Cited by 5
Perspectives in Imaging: Present and Future Prospects of Clinical Molecular Imaging
Piwnica-Worms, D. (2003) · Cited by 5
Endothelial cell spreading on lipid bilayers with combined integrin and cadherin binding ligands
Koçer, G., Albino, I., Verheijden, M. L., & Jonkheijm, P. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116850 · Cited by 4
Shih, C.-H., Chiang, T.-B., & Wang, W. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.046 · Cited by 4
Progress on the HIF-1α/VEGF/VEGFR2 signal pathway in hepatic alveolar echinococcosis
Xu, M. Q., Ke, F., Chai, J., Jide, A., & Tan, Q.-L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1553125 · Cited by 3
Tumor Angiogenesis and Modulators
Xu, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95139 · Cited by 3
Vascular Zip Codes and Nanoparticle Targeting
Ruoslahti, E. I. (2006) · Springer eBooks · doi:10.1007/978-0-387-25844-7_7 · Cited by 2
MACROMOLECULAR CARRIERS FOR DRUG TARGETING
Schacht, E. H., Winne, K. D., Hoste, K., & Vansteenkiste, S. O. (2003) · Elsevier eBooks · doi:10.1016/b978-012744481-9/50038-6 · Cited by 2
Molecular Imaging in Drug Discovery and Development: Potential and Limitations of Nonnuclear Methods
Rudin, M., Rausch, M., & Stoeckli, M. (2004) · Molecular Engineering · doi:10.1007/s11307-005-0954-7 · Cited by 2
Tumour Angiogenesis in Breast Cancer
Singh, P. G., Basalingappa, K. M., Gopenath, T. S., & Sushma, B. V. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102944 · Cited by 2
Integrins: Targets for Anti-Angiogenic Therapy
Kisker, O. (2007) · Springer eBooks · doi:10.1007/978-3-540-33177-3_42 · Cited by 2
Angiogenesis and Lymphangiogenesis in Colon Cancer Metastasis
Garnier, D., & Rak, J. W. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_9 · Cited by 1
VEGF and PDGF Receptors: Biologic Relevance and Clinical Approaches to Inhibition
Lam, J. S., Figlin, R. A., & Belldegrun, A. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_7 · Cited by 1
Insights into defibrotide as therapy for veno-occlusive disease #
Gamble, J. R., Vadas, M. A., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22770 · Cited by 1
Surface modification of a polymeric contrast agent for cancer targeting
Leodore, L. M., Oum, K. L., Lathia, J. D., & Wheatley, M. A. (2005) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2005.1431964 · Cited by 1
Development of In Vitro Method for Assaying Anti-Angiogenic Effect of Drugs
Akita, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803963-2.50002-8 · Cited by 1
Paredes, N., & Chan, A. K. C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-339-8_3 · Cited by 1
Angiogenesis: Cellular and Molecular Aspects of Postnatal Vessel Formation
Mouta, C., Liaw, L., & Maciag, T. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50698-7 · Cited by 1
Surface modification of PLGA microspheres for targeting
Lathia, J. D., El‐Sherif, D. M., Dhoot, N. O., & Wheatley, M. A. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2002.999547 · Cited by 1
The Laminins and their Receptors
Ferletta, M. (2002) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
4 Angiogenesis, Metastasis, and Epigenetics in Cancer
Plumb Claire, L., & Coomber, B. L. (2005) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(05)80059-5
Immunotherapy of Angiogenesis with DNA Vaccines
Hung, C., Monie, A., & Wu, T. ‐. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_39
Dynamics of Cell Adhesion Interactions during Melanoma Development
Li, G., & Herlyn, M. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_5
Grigoriu, B.-D., & Lassalle, P. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Anti‐angiogenic and Anti‐stromal Therapy
Bhattacharyya, M. (2007) · The Cancer Handbook · doi:10.1002/9780470025079.chap93.pub2
Modified 3D-Fibrin Matrices in Tissue Engineering for Stimulation of Angiogenesis and Wound Healing
Hall, H. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_1
Analysis of Integrin Function by Gene Targeting in Mice
Brandau, O., & Fässler, R. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_7
Engineered Materials to Measure and Regulate Cell Mechanotransduction
Blakely, B. L. (2014) · ScholarlyCommons (University of Pennsylvania)
Ultrasound contrast agents targeted to malignancies: optimizing cellular attachment
Oum, K. L., Vega, J., Leodore, L. M., Forsberg, F., Liu, J. B., Merton, D. A., & Wheatley, M. A. (2005) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2005.1431989
Glycoprotein IIb/IIIa Antagonists
Coller, B. S. (2003) · doi:10.1007/978-1-59259-376-7_4
Lathia, J. D., Oeffinger, B. E., Barbee, K. A., & Wheatley, M. A. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2003.1216043
Peptide surface modification of PLA ultrasound contrast agent for targeting
Leodore, L. M., Lathia, J. D., & Wheatley, M. A. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2003.1216059
Modification of surfactant contrast agent for targeted ultrasound imaging
Oeffinger, B. E., Lathia, J. D., Dhoot, N. O., Barbee, K. A., & Wheatley, M. A. (2003) · IEEE Annual Northeast Bioengineering Conference (NEBEC) · doi:10.1109/nebc.2003.1216117
286. Conditionally Replicating Adenoviral Vectors for Glioblastoma Treatment
(2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.06.223
TGFβ signal transduction in endothelial cells.
Valdimarsdóttir, G. (2004) · Uppsala University Publications (Uppsala University)
Angiogenesis: A Promising Target for Cancer Prevention
Ali, I. (2003) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08602-5_10
Vascular Endothelial Growth Factor Family and Its Receptors
Hicklin, D. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-184-0_1
Baron‐Menguy, C. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Pimenta, L. D. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-24022016-145853
Microfluidic Devices as In-Vitro Microenvironments for Stem Cell Culture
Shamloo, A., Abeddoust, M., & Mehboudi, N. (2014) · doi:10.2316/p.2014.818-067
Modulation of Integrin Function by Endoproteolytic Processing: Role in Tumour Progression
Rigot, V., & Luis, J. (2007) · Springer eBooks · doi:10.1007/1-4020-5132-8_6
The role of Agrin in tumor angiogenesis
Njah, K. (2019) · doi:10.32657/10356/137098
Biological and molecular properties of a new A v B 3 /A v B 5 integrin antagonist
Belvisi, L., Riccioni, T., Marcellini, M., Vesci, L., Chiarucci, I., Efrati, D., Potenza, D., Scolastico, C., Manzoni, L., Lombardo, K., et al. (2005)
Streuli, C. H. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1026616.323431
Javerzat, S., Franco, M., Herbert, J. J., Platonova, N., Peille, A.-L., Pantesco, V., Vos, J. D., Assou, S., Bicknell, R., Bikfalvi, A., et al. (2010) · PLoS ONE · doi:10.1371/annotation/110bdc8c-b16e-4043-816c-a3f8105ca061
SCUBE3 Serves as an Independent Poor Prognostic Factor in Breast CancerPreprint
Huo, Q., He, X., Li, Z., Yang, F., He, S., Shao, L., Hu, Y., Chen, S., & Xie, N. (2020) · Research Square · doi:10.21203/rs.3.rs-129257/v1
SCUBE3 serves as an independent poor prognostic factor in breast cancerPreprint
Huo, Q., He, X., Li, Z., Yang, F., He, S., Shao, L., Hu, Y., Chen, S., & Xie, N. (2021) · Research Square · doi:10.21203/rs.3.rs-129257/v2
Leading Roles of Heparan Sulfate in Angiogenesis and Cancer
Lopes, C. C., Onyeisi, J. O. S., Meneghetti, M. C. Z., Melo, C. M., Vicente, C. M., de Azevedo, L. C., Pinhal, M. A. D. S., Toma, L., & Nader, H. B. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-031-19616-4_9
Data from Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2023) · doi:10.1158/0008-5472.c.6495642
Data from Tumor αvβ3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases
Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P., Peyruchaud, O., Baron, R., Clément-Lacroix, P., & Clézardin, P. (2023) · doi:10.1158/0008-5472.c.6495642.v1
Additional file 2 of SCUBE3 serves as an independent poor prognostic factor in breast cancer
Huo, Q., He, X., Li, Z., Yang, F., He, S., Shao, L., Hu, Y., Chen, S., & Xie, N. (2021) · Figshare · doi:10.6084/m9.figshare.14615374
Halder, S. K., Delorme-Walker, V., & Milner, R. (2024) · Figshare · doi:10.6084/m9.figshare.26601559
Additional file 1 of SCUBE3 serves as an independent poor prognostic factor in breast cancer
Huo, Q., He, X., Li, Z., Yang, F., He, S., Shao, L., Hu, Y., Chen, S., & Xie, N. (2021) · Figshare · doi:10.6084/m9.figshare.14615371
Halder, S. K., Sapkota, A., & Milner, R. (2024) · Figshare · doi:10.6084/m9.figshare.26695872
Bücker, N. C. F. (2012) · Americanae (AECID Library)
Design of artificial microtissues
Kelm, J. M. (2005) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005064702
Metadata
- Authors
- Eliceiri, B. P., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Cheresh, David A
- Venue
- Current Opinion in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 13
- Issue
- 5
- Pages
- 563-568
- ISSN
- 0955-0674 (ISSN-L)
- OpenAlex
- W2103963843
- Cited by
- 287
- References
- 68
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 8 · 2013: 13 · 2012: 7
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Cancer Institute (CA-50286, CA-45726, R01CA045726, CA 78045, P01CA078045)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- angiogenesis, endothelial cell adhesion, integrins, cadherins, growth factor receptors, signaling pathways, angiogenesis inhibitors
- MeSH terms
- Cell Adhesion, Endothelium, Vascular, Extracellular Matrix, Humans, Neovascularization, Pathologic, Antigens, CD, Integrins, Receptors, Growth Factor, Neovascularization, Physiologic, Angiogenesis Inhibitors, Integrin alphaV
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review